Aclaris initiates phase II trial of ATI-501 for alopecia totalis and alopecia universalis June 27, 2018
Argenx reports cohort 1 interim data from phase II study of efgartigimod in pemphigus vulgaris June 20, 2018
Rapalimus gel launched in Japan for the treatment of angiofibromas in tuberous sclerosis June 11, 2018
RSS